Skip to content

Whole Genome Sequencing in Breast Cancer

Whole Genome Sequencing in Breast Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008426
Enrollment
1200
Registered
2023-05-12
Start date
2022-08-25
Completion date
Unknown
Last updated
2023-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Genome Insight
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Patients who consented to the subject consent form and human derived materials consent form ? Patients aged 19 years or older on the date of signing the consent form ? Patients with the ability to give written consent to voluntarily participate in this study ? Patients who can collect specimens through biopsy and surgical procedure ? A patient with histologically confirmed breast cancer or a patient who has cancer findings through imaging and undergoes a biopsy for pathological confirmation

Exclusion criteria

Exclusion criteria: ? Patients who do not understand or do not consent to written consent ? Patients who are unable to obtain sufficient specimens ? Patients who do not consent to genetic testing

Design outcomes

Primary

MeasureTime frame
Identification and evaluation of individual genetic characteristics of breast cancer patients through whole genome analysis and observation items

Secondary

MeasureTime frame
Correlation evaluation between whole genome analysis results and genetic subtypes of cancer

Countries

Korea, Republic of

Contacts

Public ContactJiin Ryu

Samsung Medical Center

ryujiin1230@gmail.com+82-2-2148-7652

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026